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RESEARCH ARTICLE
Relationship between the severity of mitral regurgitation, left ventricular dysfunction 
and plasma brain natriuretic peptide level: An observational strain imaging study
Mitral yetersizliği şiddeti, sol ventrikül fonksiyon bozukluğu ve plazma beyin natriüretik peptit 
düzeyi arasındaki ilişki: Bir gözlemsel strain görüntüleme çalışması
Mehmet Ali Elbey1, Şakir Arslan2, Enbiya Aksakal2, Hüseyin Şenocak2, Şule Karakelleoğlu2, Zuhal Arıtürk1, 
Ebru Öntürk Tekbaş1, Habib Çil1
ÖZET
Amaç:  Bu  çalışmada  mitral  yetersizliği  ve  strain/strain 
rate (S/SR) ekokardiyografi ile tespit edilen sol ventrikül 
disfonksiyonunun  derecesi  ile  plazma  beyin  natriüretik 
peptid seviyesi arasındaki ilişkinin araştırılması amaçlan-
mıştır.
Gereç ve yöntem: Mevcut çalışma kesitsel, gözlemsel bir 
çalışmadır. Bu çalışmaya polikliniğimize başvurmuş olan 
ardışık 31 mitral yetersizliği hastası (15’i [%48,4] erkek) 
ve kontrol grubu olarak 25 sağlıklı birey (12’si [%48,0] er-
kek) alınmıştır. Hastalar orta derecede mitral yetmezliği 
olanlar (n=14 [%45,2] ve ileri derecede mitral yetmezliği 
olanlar (n=17 [%54,8] olarak iki gruba ayrılmışlar ve üç 
grupta sol ventrikül duvar segmentlerinin maksimum stra-
in / strain rate ölçümleri kaydedilmiş, plazma beyin natriü-
retik peptit seviyeleri ölçülmüştür.
Bulgular: İleri MY olan hastalarda orta MY ve kontrol gru-
bu ile karşılaştırıldığında ileri MY grubunda sol ventrikül 
segment S/SR değerlerinde daha belirgin azalma izlendi 
(p<0,001).
Sonuç: MY olan hastaların her ne kadar konvansiyonel 
ekokardiyografik olarak sol ventrikül fonksiyonları normal 
olmasına rağmen ileri MY olan grubun sol ventrikül fonk-
siyonlarında subklinik bozulma izlendi.
Anahtar kelimeler:  Strain/strain  rate,  ekokardiyografi, 
mitral yetersizliği, sol ventrikül fonksiyonları
ABSTRACT
Objectives: The aim of the this study was to investigate 
the relationship between the degree of mitral regurgita-
tion (MR), left ventricular (LV) dysfunction determined by 
strain (S)/strain rate (SR) imaging and plasma brain natri-
uretic peptide (BNP) levels.
Materials and methods: This is an observational cross-
sectional study which included 31 consecutive patients 
(15[48.4%] male) who had applied to our outpatient clin-
ics  and  diagnosed  as  mitral  regurgitation  and  25  (12 
[48.0%] male) healthy persons as control subjects. The 
mitral regurgitation patients were divided into two groups: 
those with moderate MR (n=14[45.2%]) and those with 
severe MR (n=17[54.8%]), and maximum strain / strain 
rate measurements of left ventricular wall segments and 
plasma brain natriuretic peptide levels were determined in 
these two groups and controls. 
Results: S/SR values of all wall segments of left ventricle 
were found to be decreased in patient with severe MR 
when  compared  with  the  control  subjects  and  patients 
with moderate MR (p<0.001).
Conclusions: Although left ventricle functions with con-
ventional echocardiography in patients with mitral valve 
regurgitation  were  normal,  subclinic  deteriorations  of 
left ventricle were detected in patients with severe mitral 
valve regurgitation. J Clin Exp Invest 2012; 3 (4): 451-456
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INTRODUCTION
Mitral regurgitation (MR) is common and the sever-
ity of regurgitation tends to increase with age.1 Due 
to adaptive remodeling of the left ventricle (LV) and 
left atrium (LA), patients can remain asymptomatic 
or  minimally  symptomatic  for  prolonged  periods, 
even in the presence of severe MR. However, MR 
goes with a progressive remodeling of LV, leading 
eventually  to  the  development  of  LV  dysfunction, 
which  may  be  irreversible.2  However,  the  difficul-
ties  in  detecting  early  LV  dysfunction,  accurately 
assessing  the  severity  of  the  valve  involvement, 
or recognizing early cardiac symptoms often make 
it difficult to determine the optimal timing of mitral 
valve surgery.3 On the other hand, the management 
of asymptomatic patients with severe MR remains 
controversial.
Left ventricle ejection fraction (EF) is an impor-
tant determinant in mitral valve surgery in patients 
with mitral regurgitation, but in some instances it 
is difficult to properly measure EF because of ab-
normally shaped ventricles or poorly defined endo-
cardium.4 Despite the ability to identify changes in 
global LV function in MR, none have been able to 
identify subclinical LV dysfunction.5,6
Tissue Doppler imaging (TDI), strain and strain 
rate (SR) echocardiography are emerging real time 
ultrasound  techniques  that  provide  a  measure  of 
wall motion. They offer an objective means to quan-
tify global and regional left or right ventricular func-
tion and to improve the accuracy and reproducibility 
of conventional echocardiography studies.7 A num-
ber of studies also suggest that SR imaging may 
also be able to detect subclinical LV dysfunction in 
a variety of diseases before the development of ab-
normalities in conventional measures of LV perfor-
mance, such as ejection fraction.2
Recently,  it  was  reported  in  several  studies 
that, subclinical LV dysfunction was demonstrated 
via that imaging methods in patients having MR and 
normal LV function with traditional echocardiogra-
phy.2,5,6 But in these studies, commonly, particular 
segments of LV were evaluated. However, in this 
study, we evaluated all of the LV segments globally. 
In addition, natriuretic peptide levels as a new bio-
chemical marker provides an additional method for 
assessing the severity and symptoms of MR when 
the LV EF is normal.8 In the literature it has been 
demonstrated relationship between the severity and 
symptoms of MR and plasma natriuretic peptide lev-
els.1,8 But systolic S/SR and brain natriuretic peptide 
(BNP) levels together have not been studied previ-
ously in MR patients.
The aim of this study was to investigate the 
subclinical LV dysfunction evaluated by S/SR anal-
ysis and plasma levels of BNP in patients with iso-
lated MR. 
MATERIALS AND METHODS
Study design: A cross-sectional observational trial 
was performed.
Study population
Thirty-one patients (15 men) referred for echocar-
diography, who had isolated and organic moderate 
to severe mitral regurgitation were included. As a 
control group, 25 healthy (12 male) aged-matched 
subjects  were  enrolled  to  the  study.  All  patients 
were asymptomatic or minimally symptomatic and 
the echocardiographic examination was requested 
on the basis of the presence of a systolic murmur. 
MR was originated from degeneration, mitral valve 
prolapse  or  chronic  rheumatic  disease.  Patients 
were excluded if they had MR due to ischemic heart 
disease or cardiomyopathy, had associated mitral 
stenosis or any other form of valve disease, history 
of coronary artery disease, cordal rupture associ-
ated coronary artery disease, atrial fibrillation and 
arterial  hypertension.  Patients  with  suspicion  of 
coronary  artery  disease  had  undergone  exercise 
electrocardiography or angiography.
The study protocol was approved by the local 
Medical Ethics Committee and all participants gave 
informed consent.
Study protocol
All patients underwent a complete cardiac exami-
nation by a cardiologist. All individuals underwent 
standard echocardiographic and Doppler examina-
tions.
Study  variables:  baseline  variables,  predictor 
variable- mitral regurgitation, primary outcome vari-
ables- SR and S, secondary outcome variable-BNP
Echocardiography
All  individuals  underwent  standard  echocardio-
graphic and Doppler examinations using Vivid 7 (GE 
Vingmed  Ultrasound,  Horten,  Norway).  Conven-
tional LV M-mode measurements included the es-
timation of left ventricular end-diastolic dimension, 
left ventricular end-systolic dimension, thickness of 
interventricular septum and LV ejection fraction. LV 
end-systolic and end-diastolic dimensions, the LV 
ejection fraction and LA dimensions were measured 
according to the guidelines of the American Society Elbey et al. Cardiac dysfunction and BNP 453
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of  Echocardiography  (9).  Mitral  regurgitation  was 
graded as moderate if the valve ERO was 0.20-0.39 
cm2 and regurgitant volume was 30-59 mL, severe 
mitral regurgitation if it was > 0.4 cm2 and mitral 
regurgitant volume >60 mL (10).
Doppler examination
LV filling was assessed by measuring inflow at the 
tips of the leaflets of the mitral valve using pulsed 
Doppler. The following Doppler-derived parameters 
were  measured:  early  diastolic  peak  flow  veloc-
ity (E), late diastolic velocity (A), and deceleration 
time of early filling (DT). Isovolumic relaxation time 
(IVRT) was measured from the cessation of left ven-
tricular outflow to the onset of left ventricular inflow.
Tissue Doppler Imaging
Myocardial velocities were recorded using a stan-
dard PW Doppler technique. Peak systolic velocity 
(Sm) measured from septal and lateral annulus.
Longitudinal 2D strain and strain rate analysis: 
First, the LV walls were visualized parallel to the 
transducer in 2-dimentional imaging and the tissue 
velocity imaging (TVI) function frame rate was con-
sidered >100/s. Images were obtained with the min-
imum possible angle and maximum frame rate, only 
including the LV walls. Images including three con-
secutive sinus beats at end of the expiratory stage 
were digitally recorded. Three stable cardiac cycles 
were  stored  for  each  view  and  cineloop  formats 
were recorded on the hard disk of the echocardiog-
raphy device. All data were analyzed offline using a 
dedicated workstation (GE Echopac). Peak systolic 
SR and S during the ejection period were assessed 
for each segment analyzed. The myocardium of the 
apical views was divided in two segments (4-cham-
ber;  septal,  lateral,  2-chamber;  inferior,  anterior). 
Both longitudinal S and SR were measured from 
the basal, middle and apical segments of all walls. 
Measurements were performed just below the en-
docardium, by leaving a 10 mm distance between 
the two points. For each participant, either in pa-
tient or control groups, 12 segments were analyzed. 
Strain was defined as the instantaneous local trace 
shortening  or  lengthening  and  SR  as  the  rate  of 
shortening or lengthening. Poor quality images and 
segments with an angular difference >30 degrees 
were excluded from the study. MR grade was as-
sessed by an independent cardiologist blinded to 
the patient’s BNP results. Intraobserver variability 
was tested with Kappa analysis. The intraobserver 
coefficient of variation was <5%.
Measurement of BNP
Blood  sampling  was  obtained  for  all  patients  im-
mediately after enrollment in the echocardiograph-
ic  laboratory.  Samples  were  immediately  placed 
on ice and transferred to the laboratory facilities. 
The AxSYM (Abbott Laboratories, Abbott Park IL) 
analyzer was used for BNP assay, a microparticle 
enzyme immunoassay, is a 2-site assay that uses 
a monoclonal anti-BNP antibody and measures a 
fluorescence product.
Statistical analysis
All continuous variables were tested for skewness. 
The  continuous  parameters  were  presented  as 
mean ± standard deviation. Comparisons of demo-
graphic,  clinical  and  laboratory  characteristics  of 
the patients were performed using one way ANOVA 
test for continuous variables. Scheffe test was used 
for post hoc analysis. Kruskal Wallis test was used 
to compare abnormally distributed data. Categoric 
variables were compared with the chi-square test. 
Statistical analyses were carried out using SPSS 
13.0 for Windows and a p-value <0.05 was consid-
ered significant.
RESULTS
Clinical and echocardiographic features of the pa-
tients and the control group were summarized in 
Table 1 and 2. In patients with severe MR, IVRT was 
higher to compare with the patients of control group 
or moderate MR. E wave velocity and a wave veloc-
ity were greatest in patients with severe MR when 
compared with the values of patients with moderate 
MR and controls. Sm velocities were similar in all 
groups (p>0.05).
Longitudinal peak systolic SR values were sig-
nificantly lower in the severe MR group, when com-
pared with the controls and patients with moderate 
MR. Similarly, longitudinal peak systolic S values 
were significantly lower in the severe MR. When 
compared with the control group, strain and strain 
rates were also significantly impaired in the inferior, 
septum, anterior and lateral walls in MR patients 
(Table 3). S/SR values from segments of all walls of 
left ventricle were decreased in MR patients (Table 
4). Plasma BNP values were significantly higher in 
severe and moderate MR group when compared 
with the control subjects (Control group 36.8±9.2, 
moderate MY 81.1±15.4, severe MY 107.9±28) (Ta-
ble 2).Elbey et al. Cardiac dysfunction and BNP 454
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Table 1.  Baseline 
characteristics  of  pa-
tients  with  Mitral  Re-
gurgitation and Control 
Groups
MPV: Mitral valve pro-
lapsus,  MR:  mitral  re-
gurgitation
*  p<0.05  versus  con-
trol,  **  p<0.01  versus 
control,  ***  p<0.001 
versus control
Control (n=25) Moderate MR (n=14) Severe MR (n=17) p
Age 40 ± 11 39 ± 12 44 ± 17 0.684
Heart rate 76 ± 13 73 ± 14 76 ± 14 0.831
Male n, (%) 12 (48) 6 (43) 9 (53) 0.517
Mitral valve
Normal (%) 25 (100) 0*** 0***
Fibrotic 0 9 (62)*** 5 (29)***
Mixematous 0 7 (50)*** 10 (59)*** <0.001
MVP (%) 0 3 (21)*** 6 (35)***
Cordal rupture (%) 0 0(0.0)*** 9 (53)***
Table 2.  Comparison  of  brain  natri-
uretic peptide (BNP) and conventional 
echocardiographic  variables  of  the 
study groups.
* p<0.05 versus control, ** p<0.01 ver-
sus control, *** p<0.001 versus control
MR: mitral regurgitation
Data are presented as mean (±) stan-
dard deviation,
Control Moderate MR Severe MR p
BNP (pg /mL) 36,8 ± 9,2 81,1 ± 15,4** 107,9 ± 28*** <0.001
LVEF (mm) 64 ± 4 61 ± 5 62 ± 4 0.45
LVEDD (mm) 44 ± 5 51 ± 5*** 57 ± 4*** <0.001
LVESD (mm) 29 ± 5 34 ± 5** 37 ± 4*** 0.001
LAD (mm) 34 ± 4 46 ± 4*** 55 ± 7*** <0.0011
IVS (mm) 9 ± 1 10 ± 1 11 ± 2** 0.023
ERO (cm2) 0 0,3 ± 0,1*** 0,6 ± 0,2*** <0.001
RV (ml) 0 45 ± 13*** 84 ± 25*** <0.001
Table 3.  Comparison  of  Doppler  and 
Tissue  Doppler  values  of  the  study 
groups
Control Moderate MR Severe MR p
Mitral E wave 0,9 ± 0,2 0,9 ± 0,2 1,4 ± 0,5*** <0.001
Mitral A wave 0,6 ± 0,1 0,7 ± 0,2 0,9 ± 0,3** 0.01
DT 197 ± 55 229 ± 65* 232 ± 45* 0.04
IVRT 82 ± 12 98 ± 12* 103 ± 16* 0.03
Lateral  Sm 8 ± 2 9 ± 2 10 ± 2 0.65
Septal Sm 7 ± 2 9 ± 1 9 ± 2 0.754
* p<0.05 versus control, ** p<0.01 ver-
sus control, *** p<0.001 versus control
MR: mitral regurgitation, A: late diastol-
ic transmitral flow velocity, DT: deceler-
ation time, E:  early diastolic transmitral 
flow  velocity,  IVRT:  isovolumic  relax-
ation time, Sm: peak systolic velocity, 
Table 4. Comparison of strain (S) and 
strain rate (SR) levels in patients and 
control subjects
Control Moderate MR Severe MR p*
Lateral S (%) -18,8 ± 2,3 -16,4 ± 1,9** -13,8 ± 2,0*** <0.001
Septum S (%) -21,9 ± 3,0 -17,4 ± 3,3** -15,2 ± 1,2*** <0.001
Anterior S (%) -19,9 ± 2,4 -16 ± 1,5** -14,1 ± 1,7*** <0.001
Inferior S (%) -21,9 ± 3 -16,7 ± 2*** -13,5 ± 2,4** 0.002
Lateral SR ( s-1) -1,6 ± 0,2 -1,3 ± 0,2** -1,0 ± 0,1*** <0.001
Septum SR (s-1) -1,5 ± 0,2 -1,2 ± 0,1** -0,9 ± 0,1*** <0.001
Anterior SR ( s-1) -1,4 ± 0,2 -1,1 ± 0,1** -0,9 ± 0,1*** <0.001
Inferior SR ( s-1) -1,5 ± 0,2 -1,2 ± 0,2** -1,0 ± 0,1*** <0.001
Data are presented as mean (±) stan-
dard  deviation,  *Student’s  t-test,  MR: 
mitral regurgitation,
* p<0.05 versus control, ** p<0.01 ver-
sus control, *** p<0.001 versus controlElbey et al. Cardiac dysfunction and BNP 455
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DISCUSSION
The present study showed that BNP levels were el-
evated in patients with organic moderate or severe 
MR. S/SR values decreased significantly in patients 
with moderate to severe MR.
According to the ACC/AHA guidelines, asymp-
tomatic MR patients with an ESD ≥ 4.5 cm and an 
EF ≤ 60% benefit from valve surgery to protect ven-
tricular function. However, if ESD ≥ 4.5 cm and EF ≤ 
60% are used as a cut-off point, there is still a high 
incidence of heart failure and poor survival after sur-
gery.5,9 Thus, the measurements of ESD and EF are 
not optimal for the evaluation of subclinical ventricu-
lar dysfunction in asymptomatic patients. However, 
difficulties in detecting early LV dysfunction, accu-
rately assessing the severity of valve involvement 
and the optimal timing of surgery in patients with 
asymptomatic severe MR remains a challenge.2,5
Previous studies have shown that S increases 
as  SV  increases  and  that  deformation  rate  (SR) 
parallels change in contractility.11 But Marciniak et 
al  5 subsequently demonstrated that S/SR values 
decreased with the severity of MR. Their study pop-
ulation consisted of 77 individuals (control n = 23, 
mild MR n = 10, moderate n = 14 and severe MR n= 
30). They found that longitudinal peak systolic SR 
values and peak systolic S values were significantly 
lower in the severe MR group compared to the con-
trol cases and mild/moderate MR patients. But no 
significant  association  was  seen  between  severe 
MR group and moderate MR group. In our study, the 
decreased S/SR values were observed in patients 
with MR compared to the control cases.
In another study, SR was significantly greater 
in patients with contractile reserve compared to the 
subjects who had no contractile reserve. However 
SR was not significantly different in contractile (-) 
patients compared with normal controls.12 A number 
of studies also suggest that SR imaging may detect 
subclinical LV dysfunction in a variety of diseases 
before LV systolic function was established.13,14
Yurdakul et al  15 demonstrated that S/SR val-
ues  of  MR  severity  were  decreased.  Their  study 
population  consisted  of  54  patients  with  isolated 
non-ischemic  MR  and  30  healthy  aged  matched 
subjects were examined (mild MR n=7, moderate 
n=29 and severe MR n=18). They found that longi-
tudinal peak systolic SR values and peak systolic 
S values were significantly lower in the severe MR 
group  compared  to  the  other  groups,  which  was 
concordant with our results.
In another study, Detaint et. al1 measured BNP 
levels in 78 patients with MR. Patients with organic 
and  functional  MR  had  higher  BNP  values  com-
pared with control subjects, but the BNP levels were 
higher in patients with functional MR than those with 
organic MR. However,  mean BNP value in func-
tional MR was higher than the other groups (control 
and organic MR). In our cohort, plasma BNP values 
were significantly higher in severe MR group when 
compared  with  the  control  subjects  and  patients 
with moderate MR.
Chronic  MR  can  ultimately  lead  to  irrevers-
ible  changes  in  the  myocardium  via  progressive 
LV remodelling, with increasing wall stresses due 
to dilatation, decrease afterload, increase preload 
and changes in LV geometry. Measurement of na-
triuretic peptides and S/SR may be especially use-
ful in the follow-up of asymptomatic patients. When 
echocardiographic assessment is technically diffi-
cult, low BNP levels would suggest that MR is not 
severe. These observations suggest that BNP lev-
els provide an additional method for assessing the 
severity of MR when the LVEF is normal.
Conflicting results in previously reported stud-
ies might be explained at least in part by different 
patient selections (such as age, ethnicity, sample 
size, inclusion of patients with comorbidity) and dif-
ferent diagnostic methods or criteria.
In  patients  with  isolated  organic  MR,  S/SR 
were found to relate with plasma BNP levels, and 
thus may be considered as a new echocardiograph-
ic parameter for the assessment of global ventricu-
lar function during patient follow up. Systolic S/SR 
and  BNP  levels  together  have  not  been  studied 
previously in MR patients. S/SR imaging may also 
be used as a risk stratification tool in diagnosing 
changes in LV dysfunction at a subclinic level in pa-
tients with severe asymptomatic MR.
Our study population was relatively small. In nor-
mal  subjects,  natriuretic  peptides  increased  with 
age and as with flow Doppler, TDI velocity, strain 
rate and strain measurements are user dependent. 
Post-operative  S/SR  values  were  not  recorded 
which  would  give  more  accurate  predictability  of 
strain method in the subclinical phase.
In  conclusion,  we  think  that  S/SR  combined 
with BNP measurement may be helpful in detection 
of subclinical impairments in left ventricle functions. 
These interrelations need to be clarified with further 
studies.
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